- Home
- CCU vs KLRA Comparison
CCU vs KLRA Comparison
Compare CCU & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCU | KLRA |
|---|---|---|
| Founded | 1850 | N/A |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2001 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CCU | KLRA |
|---|---|---|
| Price | $11.17 | $12.79 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 123.5K | ★ 780.3K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.42 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.71 | $11.84 |
| 52 Week High | $15.36 | $23.82 |
Technical Indicators
Market Signals| Indicator | CCU | KLRA |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 30.66 |
| Support Level | $10.83 | N/A |
| Resistance Level | $12.15 | $19.15 |
| Average True Range (ATR) | 0.28 | 0.97 |
| MACD | -0.08 | -0.23 |
| Stochastic Oscillator | 31.25 | 12.45 |
Price Performance
Historical ComparisonAbout CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About KLRA Kailera Therapeutics Inc. Common Stock
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.